AEGR +32%/PM on Japan’s approval of Juxtapid for HoPH: http://finance.yahoo.com/news/aegerion-pharmaceuticals-juxtapid-lomitapide-capsules-200500602.html Such a sharp rise is odd insofar as AEGR is supposedly being acquired by QLTI (#msg-123312384).